Publications Emergency medicine physicians’ perspectives on diagnostic accuracy in neurology: a qualitative study
Publications An innovative approach to modelling the optimal treatment sequence for patients with relapsing–remitting multiple sclerosis: implementation, validation, and impact of the decision-making approach
Publications Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis
Thought Leadership New Policy Updates on Digital Health in the EU: Major Milestones and Critical Policy Points for Artificial Intelligence in Health and Healthcare in the EU
Publications Does biosimilar bevacizumab offer affordable treatment options for cancer patients in the USA? A budget impact analysis from us commercial and Medicare payer perspectives
Publications Development of the multiple myeloma symptom and impact questionnaire: a new patient-reported outcome instrument to assess symptom and impacts in patients with multiple myeloma
Publications Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
Publications Cost-effectiveness of a 12-month fixed duration of Venetoclax in combination with Obinutuzumab versus chemoimmunotherapy and other novel combinations in first-line chronic lymphocytic leukemia in Canada